Myasthenia Gravis and the SLP: Part 1

Introduction:

The purpose of this content is to help SLPs better understand the medical underpinnings, management and begin the deep dive into Myasthenia Gravis.

Myasthenia Gravis (MG) is a neuromuscular disorder occurring at the neuromuscular junction, where antibodies against acetylcholine block neurotransmission to muscle fibers, which results in fatigue and decreased muscle response with repetitive stimulation (Ludlow et al. 2019, p 472). Patients with MG may have periods of weakness which may affect the larynx as well as the muscles of swallowing and respiration.

Resources: